Com-Guard.Com Inc (CGUD) 0.0005 $CGUD
DUE DILIGENCE
Com-Guard.Com Inc (CGUD) 0.0005 $CGUD
DUE DILIGENCE REPORT: Com-Guard.com Shares Jump 225% in One Day Initiating Coverage
ACCESSWIRE - Wed Dec 16, 7:52AM CST
NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Com-Guard.com, Inc. (OTC: CGUD) shares closed at $.0013 up 225% yesterday. Trading volume was 135 million shares significantly higher than the daily average of 543 thousand. CGUD shares had opened at $.0008 and hit a high of $.0029 before settling down to the $.0013 closing price.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...
Continue Reading
UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...
Continue Reading
High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...
Continue Reading
Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...
Continue Reading
Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...
Continue Reading